Prolonged	prolonged	O	O	O	O
paralysis	paralysis	O	DISEASE	OTHERS	I
due	due	O	O	O	O
to	to	O	O	O	O
nondepolarizing	nondepolarizing	O	O	OTHERS	I
neuromuscular	neuromuscular	CHEMICALS	O	OTHERS	I
blocking	blocking	CHEMICALS	O	OTHERS	I
agents	agents	CHEMICALS	O	OTHERS	I
and	and	O	O	O	O
corticosteroids	corticosteroids	CHEMICALS	O	OTHERS	I
.	.	O	O	O	O

The	the	O	O	O	O
long-term	long-term	O	O	O	O
use	use	O	O	O	O
of	of	O	O	O	O
nondepolarizing	nondepolarizing	O	O	OTHERS	I
neuromuscular	neuromuscular	CHEMICALS	O	OTHERS	I
blocking	blocking	CHEMICALS	O	OTHERS	I
agents	agents	CHEMICALS	O	OTHERS	I
(	(	O	O	O	O
ND-NMBA	nd-nmba	O	O	O	O
)	)	O	O	O	O
has	has	O	O	O	O
recently	recently	O	O	O	O
been	been	O	O	O	O
implicated	implicated	O	O	O	O
as	as	O	O	O	O
a	a	O	O	O	O
cause	cause	O	O	O	O
of	of	O	O	O	O
prolonged	prolonged	O	O	O	O
muscle	muscle	O	DISEASE	OTHERS	I
weakness	weakness	O	DISEASE	OTHERS	I
,	,	O	O	O	O
although	although	O	O	O	O
the	the	O	O	O	O
site	site	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
lesion	lesion	O	O	O	O
and	and	O	O	O	O
the	the	O	O	O	O
predisposing	predisposing	O	O	O	O
factors	factors	O	O	O	O
have	have	O	O	O	O
been	been	O	O	O	O
unclear	unclear	O	O	O	O
.	.	O	O	O	O

We	we	O	O	O	O
report	report	O	O	O	O
3	3	O	O	O	O
patients	patients	O	O	O	O
(	(	O	O	O	O
age	age	O	O	O	O
37	37	O	O	O	O
-	-	O	O	O	O
52	52	O	O	O	O
years	years	O	O	O	O
)	)	O	O	O	O
with	with	O	O	O	O
acute	acute	O	O	O	O
respiratory	respiratory	O	DISEASE	OTHERS	I
insufficiency	insufficiency	O	DISEASE	OTHERS	I
who	who	O	O	O	O
developed	developed	O	O	O	O
prolonged	prolonged	O	O	O	O
weakness	weakness	O	DISEASE	OTHERS	I
following	following	O	O	O	O
the	the	O	O	O	O
discontinuation	discontinuation	O	O	O	O
of	of	O	O	O	O
ND-NMBAs	nd-nmbas	O	O	O	O
.	.	O	O	O	O

Two	two	O	O	O	O
patients	patients	O	O	O	O
also	also	O	O	O	O
received	received	O	O	O	O
intravenous	intravenous	O	O	O	O
corticosteroids	corticosteroids	CHEMICALS	O	OTHERS	I
.	.	O	O	O	O

Renal	renal	O	O	O	O
function	function	O	O	O	O
was	was	O	O	O	O
normal	normal	O	O	O	O
but	but	O	O	O	O
hepatic	hepatic	O	O	O	O
function	function	O	O	O	O
was	was	O	O	O	O
impaired	impaired	O	O	O	O
in	in	O	O	O	O
all	all	O	O	O	O
patients	patients	O	O	O	O
,	,	O	O	O	O
and	and	O	O	O	O
all	all	O	O	O	O
had	had	O	O	O	O
acidosis	acidosis	O	DISEASE	OTHERS	I
.	.	O	O	O	O

Electrophysiologic	electrophysiologic	O	O	O	O
studies	studies	O	O	O	O
revealed	revealed	O	O	O	O
low	low	O	O	O	O
amplitude	amplitude	O	O	O	O
compound	compound	O	O	O	O
motor	motor	O	O	O	O
action	action	O	O	O	O
potentials	potentials	O	O	O	O
,	,	O	O	O	O
normal	normal	O	O	O	O
sensory	sensory	O	O	O	O
studies	studies	O	O	O	O
,	,	O	O	O	O
and	and	O	O	O	O
fibrillations	fibrillations	O	O	O	O
.	.	O	O	O	O

Repetitive	repetitive	O	O	O	O
stimulation	stimulation	O	O	O	O
at	at	O	O	O	O
2	2	O	O	O	O
Hz	hz	O	O	O	O
showed	showed	O	O	O	O
a	a	O	O	O	O
decremental	decremental	O	O	O	O
response	response	O	O	O	O
in	in	O	O	O	O
2	2	O	O	O	O
patients	patients	O	O	O	O
.	.	O	O	O	O

The	the	O	O	O	O
serum	serum	O	O	O	O
vecuronium	vecuronium	CHEMICALS	O	OTHERS	I
level	level	O	O	O	O
measured	measured	O	O	O	O
in	in	O	O	O	O
1	1	O	O	O	O
patient	patient	O	O	O	O
14	14	O	O	O	O
days	days	O	O	O	O
after	after	O	O	O	O
the	the	O	O	O	O
drug	drug	O	O	O	O
had	had	O	O	O	O
been	been	O	O	O	O
discontinued	discontinued	O	O	O	O
was	was	O	O	O	O
172	172	O	O	O	O
ng/mL.	ng/ml.	O	O	O	O
A	a	O	O	O	O
muscle	muscle	O	O	O	O
biopsy	biopsy	O	O	O	O
in	in	O	O	O	O
this	this	O	O	O	O
patient	patient	O	O	O	O
showed	showed	O	O	O	O
loss	loss	O	O	OTHERS	I
of	of	O	O	OTHERS	I
thick	thick	O	O	OTHERS	I
,	,	O	O	OTHERS	I
myosin	myosin	O	O	OTHERS	I
filaments	filaments	O	O	OTHERS	I
.	.	O	O	O	O

The	the	O	O	O	O
weakness	weakness	O	DISEASE	OTHERS	I
in	in	O	O	O	O
these	these	O	O	O	O
patients	patients	O	O	O	O
is	is	O	O	O	O
due	due	O	O	O	O
to	to	O	O	O	O
pathology	pathology	O	O	OTHERS	I
at	at	O	O	OTHERS	I
both	both	O	O	OTHERS	I
the	the	O	O	OTHERS	I
neuromuscular	neuromuscular	O	O	OTHERS	I
junction	junction	O	O	OTHERS	I
(	(	O	O	O	O
most	most	O	O	O	O
likely	likely	O	O	O	O
due	due	O	O	O	O
to	to	O	O	O	O
ND-NMBA	nd-nmba	O	O	O	O
)	)	O	O	O	O
and	and	O	O	O	O
muscle	muscle	O	O	O	O
(	(	O	O	O	O
most	most	O	O	O	O
likely	likely	O	O	O	O
due	due	O	O	O	O
to	to	O	O	O	O
corticosteroids	corticosteroids	CHEMICALS	O	OTHERS	I
)	)	O	O	O	O
.	.	O	O	O	O

Hepatic	hepatic	O	O	OTHERS	I
dysfunction	dysfunction	O	O	OTHERS	I
and	and	O	O	O	O
acidosis	acidosis	O	DISEASE	OTHERS	I
are	are	O	O	O	O
contributing	contributing	O	O	O	O
risk	risk	O	O	O	O
factors	factors	O	O	O	O
.	.	O	O	O	O

